| Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2011: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Research Abstract |
In order to develop a novel therapeutic model by a novel tumor-specific drug delivery system (DDS), we tried a novel DDS by span80 nano-vesicles containing anti-tumor agent in vitro and in vivo with osteosarcoma bearing mouse model. As a result, we established a novel therapeutic model using caffeine and ifosfamide containing Span80 vesicles which manifested prominent efficiency and almost no adverse effect.
|
